Modern Management of MPNs: Recent Advances and Future Directions in ET, PV, and MF

Review the latest data and expert guidance to enhance your treatment of essential thrombocythemia polycythemia vera and myelofibrosis! This comprehensive program features focused commentaries an expert analysis module and downloadable slides.

Share

Program Content

Activities

MPN Management Slides
Optimizing Management of ET, PV, and MF
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 14, 2019

Expires: May 12, 2020

Activities

MPNs in 2019
Myeloproliferative Neoplasms: What’s New for 2019?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2019

Expires: February 24, 2020

MPN Key Clinical Issues
Practical Approaches to Managing Key Clinical Issues With Myeloproliferative Neoplasms
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 09, 2019

Expires: April 07, 2020

MPNs at ASCO/EHA 2019
Novel Treatment Strategies for Myeloproliferative Neoplasms: What’s New From ASCO and EHA 2019
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 08, 2019

Expires: July 06, 2020

Faculty

cover img faculity

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

cover img faculity

John Mascarenhas, MD

Director, Adult Leukemia Program
Leader, Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute 
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

cover img faculity

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

cover img faculity

Srdan Verstovsek, MD, PhD

Professor
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Celgene

Incyte Corporation